Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery | MicrobiomeTrials← Back to trialsNCT07486570
Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-02-01Est. Completion: 2028-02-01
Enrollment target: 360 participants Locations- Treant, Emmen, Drenthe, Netherlands
- Meander, Amersfoort, Gelderland, Netherlands
- Gelre ziekenhuis, Apeldoorn, Gelderland, Netherlands
- Zuyderland, Heerlen, Limburg, Netherlands
- Maastricht Universitair Medisch Centrum (MUMC+), Maastricht, Limburg, Netherlands
- Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, North Brabant, Netherlands
- Noordwest Ziekenhuisgroep, Alkmaar, North Holland, Netherlands
- Spaarne Gasthuis, Haarlem, North Holland, Netherlands
- Ziekenhuisgroep Twente, Almelo, Overijsel, Netherlands
- Medisch Spectrum Twente, Enschede, Overijsel, Netherlands
- Nij Smellinghe, Drachten, Provincie Friesland, Netherlands
- Martini Ziekenhuis, Groningen, Provincie Groningen, Netherlands
- Universitair Medisch Centrum Groningen, Groningen, Provincie Groningen, Netherlands
- Franciscus, Rotterdam, South Holland, Netherlands
- Maasstad ziekenhuis, Rotterdam, South Holland, Netherlands
- Haaglanden Medisch Centrum, The Hague, South Holland, Netherlands
- Diakonessenhuis, Utrecht, Utrecht, Netherlands
- Albert Schweitzer ziekenhuis, Dordrecht, Zuid, Netherlands
Other microbiome trials you might be interested in
Transfusion-dependent AnemiaSurgeryAnemia
In this prospective, multicentre, open, randomised, controlled clinical trial elderly patients (≥ 70 years) undergoing i…
Aachen, GermanyCompleted Jun 30, 2025
Membranous NephropathyNephrotic Syndrome
The primary objective of this study is to evaluate the effectiveness of belimumab and intravenous rituximab co-administr…
Birmingham, United StatesEst. completion Mar 1, 2029